Plus Vitech is in a strategic position to carry out innovative advantages of the liquid biopsy, the companion diagnostic and the treatment field.
Our company specializes in circulating tumor DNA (ctDNA) and biomarker analysis from a blood sample, known as a liquid biopsy. This kind of biopsy will furnish an easier process for doctors and patients to supply responsive, personalized, and effective treatment solutions.
On the other hand, the target gene will be a promising opportunity to discover and develop treatment agents against different types of cancer. The company is developing small molecule entities and monoclonal antibodies against this gene, which allow us to carry out drug discovery and development projects in cancer and other human diseases.